Is OPK Worth Buying in 2026?

Opko Health Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-05-24

Here’s whether Opko Health Inc. (OPK) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.

🟡
Caution

Positives: above the 50-day MA (medium-term momentum positive); 3-month momentum positive (+10.4%). Concerns: trading below the 200-day MA (long-term downtrend); 50-day MA is falling (-0.53% over 10 days); RSI 77 — overbought, elevated pullback risk. Currently 20.6% off its 52-week high. Score: -2/7.

Ready to act on this? 📈 Trade on Webull

OPK is trading below its 200-day MA ($1.30) — a key warning sign the longer-term trend is under pressure. With an RSI of 76.7, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +0.0% compares to +27.9% for SPY (trailed the market by 27.9%). The current 20.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $10,000 today
vs. S&P 500 (SPY) — same period trailed market by 27.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.30)
Above 50-day MA ($1.16)
!RSI(14) neutral zone (30–70) — currently 76.7
Positive return (+0.0%)
!Within 10% of period high (−20.6%)
Period Range $1.27
$0.98 $1.60
RSI (14) 76.7
0 · OversoldOverbought · 100

Key Metrics

Price$1.27
Period Return+0.0%
Period High$1.60
Period Low$0.98
Drawdown−20.6%
MA-50$1.16
MA-200$1.30
RSI (14)76.7
Avg Volume (30d)2.4M
vs. SPYtrailed by 27.9%
Return Rank#730 of 1236

Trade OPK

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers